Skip to content

Clinical trials

Coronavirus Infections trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Country / region: Russia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
202023
202111
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Unknown status9
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products5
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation3
I.M. Sechenov First Moscow State Medical University2
NPO Petrovax2
RSV Therapeutics LLC2
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department2
Sanofi2
St. Petersburg Research Institute of Vaccines and Sera2
AO GENERIUM1
Artgen Biotech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections39
COVID-1929
Pneumonia4
Pneumonia, Viral2
Respiratory Tract Infections2
Severe Acute Respiratory Syndrome2
Acute Lung Injury1
Community-Acquired Pneumonia1
Coronaviridae Infections1
Cytokine Release Syndrome1

Trials

Showing 76 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.